Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation
De Maria, R.; Zuccelli, G.C.; Masini, S.; Caroli, A.; Brando, B.; Gronda, E.; Donato, L.
Transplantation Proceedings 21(1 Pt 1): 440-441
1989
ISSN/ISBN: 0041-1345 PMID: 2650169 Document Number: 330080
Document emailed within 1 workday
Related Documents
Sopeña, B.; Fernández-Rodríguez, C.M.; Martínez Vázquez, C.; Méndez, M.X.; de la Fuente, J.; Freire, M.; Arnillas, E.; Outon, A. 1998: Serum levels of soluble interleukin-2 receptor in alcoholic patients Anales de Medicina Interna 15(4): 189-193Cacciola, E.; Calogero, D.; Marra, G.; Guglielmo, P. 1992: Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia Bollettino della Societa Italiana di Biologia Sperimentale 68(4): 259-262
Pui, C.H.; Hudson, M.; Luo, X.; Wilimas, J.; Evans, W.; Crist, W.M. 1993: Serum interleukin-2 receptor levels in Hodgkin disease and other solid tumors of childhood Leukemia 7(8): 1242-1244
Korver, K.; Radl, J.; Schellekens, P.T.; Vossen, J.M. 1988: Transient increase of serum IgD levels after allogeneic bone-marrow transplantation Clinical and Experimental Immunology 72(2): 337-343
Lucherini, O.M.; Vitale, A.; Obici, L.; Sota, J.; Frediani, B.; Merlini, G.; Rigante, D.; Cantarini, L. 2019: Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) Clinical and Experimental Rheumatology 37 Suppl 121(6): 159-160
Arun, B.; Curti, B.D.; Longo, D.L.; Stevens, D.; Alvord, W.G.; Gause, B.L.; Watson, T.; Kopp, W.C.; Janik, J.E. 2000: Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia Cancer Journal From Scientific American 6(1): 21-24
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Wang, Q.; Zhan, F.-x.; Shan, N.-n.; Hou, M.; Yang, X.-j.; Lu, N.; Wang, H.-c.; Zhang, X.-l.; Ji, X.-b.; Ji, C.-y. 2010: Expression of interleukin-18 and interleukin-18 receptor alpha chain of the peripheral white blood cells in immune thrombocytopenia Zhonghua Nei Ke Za Zhi 49(4): 316-319
Maekawa, H.; Ishiyama, N.; Furuya, N.; Nakahara, K.; Saito, S.; Uchimura, H. 1997: Serum soluble CD8 and soluble interleukin-2-receptor levels during interferon therapy in chronic hepatitis C Rinsho Byori. Japanese Journal of Clinical Pathology 45(10): 1003-1007
Blum, A.; Miller, H. 1997: Serum-soluble interleukin-2 receptor in acute myocardial infarction and in acute heart failure Circulation 95(6): 1670-1671
Liu, W.J.; Chiang, C.H.; Huang, T.Y. 1988: The influences of serum IgE-specific suppressor factor (IgE-TsF), interleukin-2(IL-2), and interleukin-2 receptor (IL-2R) by hyposensitization to children with bronchial asthma Gaoxiong Yi Xue Ke Xue Za Zhi 4(6): 364-371
Ninomiya, Y.; Obara, A.; Sugawara, K.; Konishi, K. 1991: A study on interleukin 2 and soluble interleukin 2 receptor in serum and bronchoalveolar lavage fluid from patients with farmer's lung Nihon Kyobu Shikkan Gakkai Zasshi 29(11): 1399-1406
Sims, J.E.; Smith, D.E. 2003: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type Ii and interleukin-1 receptor accessory protein European Cytokine Network 14(2): 77-81
Nishimura, T.; Hashimoto, Y. 1984: Induction of nonspecific killer T cells from non-immune mouse spleen cells by culture with interleukin 2 Gan 75(2): 177-186
Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670
Niizeki, T.; Takeishi, Y.; Arimoto, T.; Okuyama, H.; Takabatake, N.; Tachibana, H.; Nozaki, N.; Hirono, O.; Tsunoda, Y.; Miyashita, T.; Fukui, A.; Takahashi, H.; Koyama, Y.; Shishido, T.; Kubota, I. 2005: Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure Journal of Cardiology 46(1): 9-15
Pereira, J.N.; Rabaçal, C.; Laires, M.J.; Pereira, T.; Fernandes, J.S.; Halpern, M.J. 1988: Serum and red blood cell Mg levels in acute coronary events Magnesium 7(1): 9-15
Moon, Y.; Kim, Y.; Kim, M.; Lim, J.; Kang, C.S.; Kim, W.I.; Shim, S.I.; Chung, N.G.; Park, Y.H.; Min, W.S.; Han, K. 2004: Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia Annals of Clinical and Laboratory Science 34(4): 410-415
Hiesse, C.; Lantz, O.; Kriaa, F.; Noury, J.; Fries, D.; Charpentier, B.; Bazin, H. 1991: Treatment with Lo-Tact-1, a monoclonal antibody to the interleukin-2 receptor, in kidney transplantation Presse Medicale 20(40): 2036-2038
Marta, R.; Goette, N.; Lev, P.; Heller, P.; Kornblihtt, L.; Vassallú, P.; Glembotsky, A.; Pirola, C.; Molinas, F. 2004: Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia Haematologica 89(6): 657-663